Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 28, 2012

View Archived Issues

CAP-7.1 evaluated in patients with solid tumors

Sarepta Therapeutics enters collaboration for DMD drug

miRNA-768-3p is downregulated in human GBM cells

Autophagy-related proteins correlate with acute myelogenous leukemia prognosis

Lilly Japan set to launch Zyprexa intramuscular injection

EMA accepts for review MAAs for vintafolide and etarfolatide

Novel IL-4/IL-13 binding proteins patented by Janssen Biotech and Molecular Partners

Unigene and Tarix enter licensing agreement for TXA-127

FDA clears Avaxia Biologics' IND for AVX-470

Amakem patents new ROCK-II inhibitors

ChemoCentryx begins phase I trial of CCX-872

Panacela Labs signs contract with Russian Ministry of Industry and Trade

Novel agents for the treatment of myocardial infarction disclosed by Grindeks

MMRF partners with the Department of Veterans Affairs

Gilead Sciences reports results from phase III sofosbuvir trial

Johns Hopkins researchers develop pan-malaria transmission-blocking vaccine

Phase III pimavanserin study meets primary endpoints

Japanese scientists present new humanized monoclonal antibodies

Ruga presents next-generation B-raf V600E inhibitors

Amgen synthesizes novel protein kinase inhibitors

Phase II study of ProHema for hematologic malignancies begins

U.K.'s NICE selects ThromboGenics' Jetrea for single technology appraisal

Trial of Bayer's investigational hemophilia treatment completes recruitment of first cohort

European Commission approves Viread for two new indications

Forest Laboratories submits NDA for cariprazine in two mental health disorders

Almirall reports novel PI3Kdelta inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...